November 12, 2009 – Catheter-directed therapy or catheter-directed thrombolysis to dissolve dangerous blood clots in the lungs saves lives and should be considered a first-line treatment option for massive pulmonary embolism, according to researchers in the November Journal of Vascular and Interventional Radiology.

November 12, 2009 – The first enrollments were made this week in the global Attain Success trial that will evaluate implant success, complication rates and procedure times in the market-released Attain Family of left-heart leads and delivery systems portfolio from Medtronic.

November 10, 2009 – FDA and Edwards Lifesciences notified healthcare professionals this week about the class 1 FDA recall of CardioVations EndoClamp Aortic Catheter, due to the potential that the balloon catheters may spontaneously rupture during surgery.


The incidence of cardiac arrhythmia is expected to increase significantly with an aging U.S. population and rising rates of obesity. In 2008, atrial fibrillation (AF), the most common complex arrhythmia, affected between 3 and 5 million people in the United States.

November 10, 2009 – The latest data from seven studies focused on the treatment of peripheral arterial disease (PAD) were presented in the late-breaking trials session of the Vascular Interventional Advances (VIVA) 2009 annual meeting, which took place on Oct. 19 to 23 in Las Vegas.

COBEST


The buzz words “access to healthcare” have recently been at the center of many political campaigns and government appropriations. However, to fully understand the importance of “access to healthcare” you need to look at how it impacts ordinary Americans.

In a crowded Boston North Station, three bystanders waiting for a train heard a man cry out and immediately sprang into action. They removed his shirt, started chest compressions and cleared his airway while a transit police officer ran to get the station’s automated external defibrillator (AED). They shocked the man’s heart with the AED, saving his life.

November 10, 2009 – Onset Medical Corp. today said it received U.S. FDA 510(k) marketing clearance for its SoloPath TransFemoral Endovascular Access Catheter. It is designed to provide access to diseased arteries at a relatively small catheter size and then is expanded to provide a conduit for the delivery of larger diameter devices.

November 10, 2009 – Covidien said yesterday it will voluntarily contraindicate the use of its Optimark gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance imaging (MRI) procedures involving patients with severe renal impairment.

November 10, 2009 – Clinically, stent fracture has been reported in 1-2 percent of patients after drug-eluting stent (DES) implantation, but researchers at the CVPath Institute Gaithersburg, Md. and? Emory University School of Medicine, Atlanta, say the amount of fractures is actually much higher at about 29 percent.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now